A detailed history of Sofinnova Investments, Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Sofinnova Investments, Inc. holds 61,494 shares of DXCM stock, worth $4.24 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
61,494
Holding current value
$4.24 Million
% of portfolio
0.39%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$110.31 - $140.45 $6.78 Million - $8.64 Million
61,494 New
61,494 $6.97 Million
Q4 2023

Aug 15, 2024

SELL
$75.49 - $124.16 $3.13 Million - $5.15 Million
-41,494 Reduced 67.48%
20,000 $2.48 Million
Q4 2023

Feb 12, 2024

SELL
$75.49 - $124.16 $26.5 Million - $43.5 Million
-350,720 Reduced 94.61%
20,000 $2.48 Million
Q2 2023

Aug 14, 2023

BUY
$112.47 - $130.98 $12.8 Million - $14.9 Million
113,493 Added 44.12%
370,720 $47.6 Million
Q1 2023

May 11, 2023

BUY
$104.0 - $122.92 $12.1 Million - $14.3 Million
116,549 Added 82.85%
257,227 $29.9 Million
Q4 2022

Feb 13, 2023

SELL
$84.98 - $122.67 $5.55 Million - $8.01 Million
-65,270 Reduced 31.69%
140,678 $15.9 Million
Q3 2022

Nov 08, 2022

BUY
$76.35 - $94.18 $1.29 Million - $1.59 Million
16,856 Added 8.91%
205,948 $16.6 Million
Q2 2022

Aug 15, 2022

BUY
$67.99 - $132.89 $10.1 Million - $19.8 Million
148,827 Added 369.62%
189,092 $14.1 Million
Q1 2022

May 16, 2022

BUY
$94.08 - $130.2 $739,562 - $1.02 Million
7,861 Added 24.26%
40,265 $20.6 Million
Q4 2021

Feb 14, 2022

SELL
$129.87 - $162.82 $631,427 - $791,630
-4,862 Reduced 13.05%
32,404 $17.4 Million
Q3 2021

Nov 15, 2021

BUY
$106.71 - $143.18 $379,140 - $508,718
3,553 Added 10.54%
37,266 $20.4 Million
Q2 2021

Aug 16, 2021

BUY
$80.99 - $107.93 $543,685 - $724,534
6,713 Added 24.86%
33,713 $14.4 Million
Q1 2021

May 14, 2021

BUY
$84.79 - $104.74 $2.29 Million - $2.83 Million
27,000 New
27,000 $9.7 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $26.6B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Sofinnova Investments, Inc. Portfolio

Follow Sofinnova Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sofinnova Investments, Inc. with notifications on news.